Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Shares Issued (2020 - 2025)

Agilon Health (AGL) has disclosed Shares Issued for 6 consecutive years, with -$161000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Shares Issued fell 108.9% year-over-year to -$161000.0, compared with a TTM value of -$803000.0 through Mar 2025, down 119.65%, and an annual FY2025 reading of -$3.0 million, down 356.56% over the prior year.
  • Shares Issued was -$161000.0 for Q1 2025 at Agilon Health, down from -$22000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $16.5 million in Q4 2021 and bottomed at -$787000.0 in Q2 2023.
  • Average Shares Issued over 5 years is $3.8 million, with a median of $1.1 million recorded in 2021.
  • The sharpest move saw Shares Issued skyrocketed 8843.03% in 2022, then plummeted 114.16% in 2023.
  • Year by year, Shares Issued stood at $16.5 million in 2021, then plummeted by 85.56% to $2.4 million in 2022, then crashed by 82.98% to $405000.0 in 2023, then crashed by 105.43% to -$22000.0 in 2024, then tumbled by 631.82% to -$161000.0 in 2025.
  • Business Quant data shows Shares Issued for AGL at -$161000.0 in Q1 2025, -$22000.0 in Q4 2024, and -$156000.0 in Q3 2024.